Brean Sees 200+% Upside In Shares Of Evoke Pharma

By: via Benzinga
In a report published Thursday, Brean Capital analyst Difei Yang initiated coverage of Evoke Pharma Inc (NASDAQ: EVOK) with a Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.